Gordon LI - Search Results

1

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma.

Allen PB, Savas H, Evens AM, Advani RH, Palmer B, Pro B, Karmali R, Mou E, Bearden J, Dillehay G, Bayer RA, Eisner RM, Chmiel JS, O'Shea K, Gordon LI, Winter JN. Allen PB, et al. Among authors: gordon li. Blood. 2021 Mar 11;137(10):1318-1326. doi: 10.1182/blood.2020007400. Blood. 2021. PMID: 32992341 Free PMC article. Clinical Trial.

2

Combined therapy with rG-CSF and GM-CSF for the mobilization of hematopoietic progenitor cells.

Winter JN, Mangan C, Bryd K, Tallman M, Gordon L, Jahnke L, Lazarus H, Cooper B, Crum E, Horvath N, et al. Winter JN, et al. Prog Clin Biol Res. 1994;389:463-70. Prog Clin Biol Res. 1994. PMID: 7535455 Clinical Trial. No abstract available.

3

Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial.

Wiseman GA, Gordon LI, Multani PS, Witzig TE, Spies S, Bartlett NL, Schilder RJ, Murray JL, Saleh M, Allen RS, Grillo-López AJ, White CA. Wiseman GA, et al. Among authors: gordon li. Blood. 2002 Jun 15;99(12):4336-42. doi: 10.1182/blood.v99.12.4336. Blood. 2002. PMID: 12036859 Free article. Clinical Trial.

4

Burkitt's and Burkitt-like lymphoma.

Evens AM, Gordon LI. Evens AM, et al. Among authors: gordon li. Curr Treat Options Oncol. 2002 Aug;3(4):291-305. doi: 10.1007/s11864-002-0029-9. Curr Treat Options Oncol. 2002. PMID: 12074766 Review.

5

Rarity of toxigenic Clostridium difficile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrhea.

Tomblyn M, Gordon L, Singhal S, Tallman M, Williams S, Winter J, Mehta J. Tomblyn M, et al. Bone Marrow Transplant. 2002 Oct;30(8):517-9. doi: 10.1038/sj.bmt.1703703. Bone Marrow Transplant. 2002. PMID: 12379891

6

Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies.

Shi B, Hsu HL, Evens AM, Gordon LI, Gartenhaus RB. Shi B, et al. Among authors: gordon li. Blood. 2003 Jul 1;102(1):297-302. doi: 10.1182/blood-2002-11-3486. Epub 2003 Mar 13. Blood. 2003. PMID: 12637315 Free article.

7

Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependent.

Evens AM, Prachand S, Shi B, Paniaqua M, Gordon LI, Gartenhaus RB. Evens AM, et al. Among authors: gordon li. Clin Cancer Res. 2004 Feb 15;10(4):1481-91. doi: 10.1158/1078-0432.ccr-1058-03. Clin Cancer Res. 2004. PMID: 14977852

8

Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study.

Gordon LI, Molina A, Witzig T, Emmanouilides C, Raubtischek A, Darif M, Schilder RJ, Wiseman G, White CA. Gordon LI, et al. Blood. 2004 Jun 15;103(12):4429-31. doi: 10.1182/blood-2003-11-3883. Epub 2004 Mar 11. Blood. 2004. PMID: 15016644 Free article. Clinical Trial.

9

Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells.

Evens AM, Lecane P, Magda D, Prachand S, Singhal S, Nelson J, Miller RA, Gartenhaus RB, Gordon LI. Evens AM, et al. Among authors: gordon li. Blood. 2005 Feb 1;105(3):1265-73. doi: 10.1182/blood-2004-03-0964. Epub 2004 Sep 23. Blood. 2005. PMID: 15388578 Free article.

10

Radioimmunotherapy in non-Hodgkin's lymphoma: trials of yttrium 90-labeled ibritumomab tiuxetan and beyond.

Evens AM, Gordon LI. Evens AM, et al. Among authors: gordon li. Clin Lymphoma. 2004 Oct;5 Suppl 1:S11-5. doi: 10.3816/clm.2004.s.003. Clin Lymphoma. 2004. PMID: 15498144 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

445 results

Search Page

Filters